These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 25758901

  • 21. C1q nephropathy: a pediatric clinicopathologic study.
    Iskandar SS, Browning MC, Lorentz WB.
    Am J Kidney Dis; 1991 Oct; 18(4):459-65. PubMed ID: 1928065
    [Abstract] [Full Text] [Related]

  • 22. Clinicopathologic correlation of C1q nephropathy in children.
    Fukuma Y, Hisano S, Segawa Y, Niimi K, Tsuru N, Kaku Y, Hatae K, Kiyoshi Y, Mitsudome A, Iwasaki H.
    Am J Kidney Dis; 2006 Mar; 47(3):412-8. PubMed ID: 16490619
    [Abstract] [Full Text] [Related]

  • 23. C3 glomerulopathy in children: Is there still a place for anti-cellular immunosuppression?
    Kojc N, Bahovec A, Levart TK.
    Nephrology (Carlton); 2019 Feb; 24(2):188-194. PubMed ID: 30393898
    [Abstract] [Full Text] [Related]

  • 24. Non-lupus full house nephropathy in pediatrics: Case reports.
    Guerrero GA, Guerrero LF, González T.
    Biomedica; 2020 Jun 15; 40(2):220-227. PubMed ID: 32673451
    [Abstract] [Full Text] [Related]

  • 25. C1Q nephropathy in children.
    Kersnik Levart T, Kenda RB, Avgustin Cavić M, Ferluga D, Hvala A, Vizjak A.
    Pediatr Nephrol; 2005 Dec 15; 20(12):1756-61. PubMed ID: 16247648
    [Abstract] [Full Text] [Related]

  • 26. Nephrotic syndrome with diffuse mesangial IgM deposits.
    Kobayashi Y, Shigematsu H, Tateno S, Hiki Y.
    Acta Pathol Jpn; 1982 Mar 15; 32(2):307-17. PubMed ID: 7046343
    [Abstract] [Full Text] [Related]

  • 27. IgG nephropathy - confusion and overlap with C1q nephropathy.
    Lim BJ, Hong SW, Jeong HJ.
    Clin Nephrol; 2009 Nov 15; 72(5):360-5. PubMed ID: 19863878
    [Abstract] [Full Text] [Related]

  • 28. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.
    Hsu HC, Chen WY, Lin GJ, Chen L, Kao SL, Huang CC, Lin CY.
    Histopathology; 1984 May 15; 8(3):435-46. PubMed ID: 6376323
    [Abstract] [Full Text] [Related]

  • 29. C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.
    Kim K, Son HE, Ryu JY, Lee H, Han SH, Ryu DR, Paik JH, Kim S, Na KY, Chae DW, Chin HJ, Oh SW.
    PLoS One; 2019 May 15; 14(4):e0215217. PubMed ID: 31002691
    [Abstract] [Full Text] [Related]

  • 30. C1Q Nephropathy: A Multifaceted Disease With Infrequent Diagnosis.
    Tariq N, Nasir H, Ahmed TA, Usman M, Ahmed KS.
    J Ayub Med Coll Abbottabad; 2019 May 15; 31(3):308-313. PubMed ID: 31535496
    [Abstract] [Full Text] [Related]

  • 31. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.
    Jennette JC, Hipp CG.
    Am J Kidney Dis; 1985 Aug 15; 6(2):103-10. PubMed ID: 3875286
    [Abstract] [Full Text] [Related]

  • 32. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study.
    Kari JA, Halawani M, Mokhtar G, Jalalah SM, Anshasi W.
    Saudi J Kidney Dis Transpl; 2009 Sep 15; 20(5):854-7. PubMed ID: 19736491
    [Abstract] [Full Text] [Related]

  • 33. Immunoglobulin M nephropathy nephropathy in adults and adolescents in India: a single-center study of natural history.
    Singhai AM, Vanikar AV, Goplani KR, Kanodia KV, Patel RD, Suthar KS, Patel HV, Gumber MR, Shah PR, Trivedi HL.
    Indian J Pathol Microbiol; 2011 Sep 15; 54(1):3-6. PubMed ID: 21393868
    [Abstract] [Full Text] [Related]

  • 34. Focal and segmental glomerulosclerosis. Immunohistologic study of 20 renal biopsy specimens.
    Gephardt GN, Tubbs RR, Popowniak KL, McMahon JT.
    Arch Pathol Lab Med; 1986 Oct 15; 110(10):902-5. PubMed ID: 2429634
    [Abstract] [Full Text] [Related]

  • 35. Nonsystemic mesangiopathic glomerulonephritis with "full house" immunofluorescence. Pathological and clinical observation in five patients.
    Jones E, Magil A.
    Am J Clin Pathol; 1982 Jul 15; 78(1):29-34. PubMed ID: 7048894
    [Abstract] [Full Text] [Related]

  • 36. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
    Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ.
    Kidney Int; 2012 Aug 15; 82(4):465-73. PubMed ID: 22673887
    [Abstract] [Full Text] [Related]

  • 37. C1q nephropathy and minimal change nephrotic syndrome.
    Wong CS, Fink CA, Baechle J, Harris AA, Staples AO, Brandt JR.
    Pediatr Nephrol; 2009 Apr 15; 24(4):761-7. PubMed ID: 19082635
    [Abstract] [Full Text] [Related]

  • 38. [Mesangial C3-glomerulonephritis].
    Dimitrova V, Minkova V, Belovezhdov N.
    Vutr Boles; 1991 Apr 15; 30(2):47-50. PubMed ID: 1891898
    [Abstract] [Full Text] [Related]

  • 39. Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.
    Zhang YM, Gu QH, Huang J, Qu Z, Wang X, Meng LQ, Wang F, Liu G, Cui Z, Zhao MH.
    Clin J Am Soc Nephrol; 2016 Sep 07; 11(9):1582-1589. PubMed ID: 27340287
    [Abstract] [Full Text] [Related]

  • 40. Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenström's macroglobulinemia: case report and review of the literature.
    Yahata M, Nakaya I, Takahashi S, Sakuma T, Sato H, Soma J.
    Clin Nephrol; 2012 Mar 07; 77(3):254-60. PubMed ID: 22377259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.